-
Weekly review: ADHD treatment FDA approval, peanut consumption and adolescent tolerance, and more
03 Jun 2024 16:11 GMT
… therapy to CNS stimulant medications for patients aged 6 … to the drug.
Click here for full FDA approval details. … prick tests). The follow-up trial, involving 508 participants, confirmed … The FDA has approved GSK's 200 mg belimumab (Benlysta) …
-
FDA Roundup: Eylea Biosimilars, Belimumab Autoinjector
24 May 2024 21:49 GMT
… and diabetic retinopathy.
The medications are vascular endothelial growth … Children
The FDA approved a 200 mg belimumab (Benlysta) autoinjector … “Going to the doctor’s office once every … colorectal cancer screening from biotechnology company Guardant Health. …
-
FDA Approves Belimumab Autoinjector for Pediatric Systemic Lupus Erythematosus
23 May 2024 10:13 GMT
… caregiver can administer the medicine at home via an … -site reactions. In clinical trials with SLE pediatric patients … statement. “Going to the doctor’s office once every four … -needed flexibility.”
Approval of Benlysta was granted to GlaxoSmithKline.
…
-
FDA Approves Belimumab Autoinjector for Children With Systemic Lupus Erythematosus
23 May 2024 23:33 GMT
… “Going to the doctor’s office once every … standard therapy achieved a treatment response (53%) compared … community.”
References
1. FDA approves Benlysta (belimumab) autoinjector for … press-releases/fda-approves-benlysta-belimumab-autoinjector-for-children …
-
GSK Breathes New Life Into Asthma Treatment With Depemokimab
22 May 2024 16:30 GMT
… 1 and SWIFT-2 trials, depemokimab demonstrated significant … versus placebo. The trials tested patients with severe … and specialty medicines (e.g., HIV treatments, Nucala, and Benlysta). Core … robust markets like HIV, vaccines, and respiratory ailments. We …
-
FDA Approves Belimumab Autoinjector for Pediatric Lupus
21 May 2024 21:25 GMT
… US Food and Drug Administration (FDA) has approved Benlysta (belimumab) autoinjector for … SLE can receive this treatment at home, according to … .
"Going to the doctor';s office once every … inhibitor approved for the treatment of active SLE and active …
-
FDA Approves Subcutaneous Belimumab for Patients Aged 5 With Systemic Lupus Erythematosus
20 May 2024 22:38 GMT
… pediatric patients can now receive treatment at home.1
“Lupus … damage. Going to the doctor’s office once every 4 … caregiver could administer the medication at home with an … nervous system lupus.2
References
FDA approves Benlysta (belimumab) autoinjector for …
-
FDA approves Benlysta autoinjector for at-home use in children with lupus
20 May 2024 20:14 GMT
… a drug previously available to children only through IV.
The FDA has … care provider.
The FDA has approved a Benlysta autoinjector for children with … approval for an at-home treatment is the first and only … the company.
“Going to the doctor’s office once every 4 …
-
COVID aside, vaccines and asthma drugs deliver strong quarter for GSK
01 May 2024 20:52 GMT
… , particularly in Vaccines and Specialty Medicines, including sales … of Nucala and Benlysta remained broadly stable … ultra long-acting treatment for HIV supports long … a British multinational pharmaceutical and biotechnology company with global headquarters …
-
Idiopathic Membranous Nephropathy Market Report 2032: Epidemiology Data, Therapies, Latest Approvals by DelveInsight
05 Jun 2024 13:08 GMT
… Nephropathy Drugs Uptake … Pharmaceuticals
BRUKINSA (zanubrutinib): BeiGene
SHR1459 (edralbrutinib): Reistone Biopharma/Eternity Bioscience
BENLYSTA … spontaneous remission, statins for hyperlipidemia … Nephropathy Current Treatment and Medical Practices
…